Fatty change in liver is seen with use of –
## **Core Concept**
Fatty change in the liver, also known as hepatic steatosis, occurs when there is an accumulation of excess fat in the liver cells (hepatocytes). This condition can result from various factors, including metabolic disorders, certain medications, and toxins. The underlying principle involves an imbalance in lipid metabolism within the liver.
## **Why the Correct Answer is Right**
The correct answer, , is associated with the use of certain medications that can disrupt normal lipid metabolism in the liver, leading to fatty change. One well-known class of drugs that can cause this effect is the corticosteroids and some antiretroviral drugs, but most notably, it is associated with the use of **tetracycline** and **nucleoside reverse transcriptase inhibitors (NRTIs)**, among others. The mechanism often involves mitochondrial dysfunction or interference with the normal process of lipid metabolism within hepatocytes.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, while certain medications and conditions can lead to fatty liver, the specific association of this option with fatty liver change is not as strongly established or recognized as that of the correct answer.
- **Option B:** Similarly, this option does not have a well-established link to fatty liver changes that is widely recognized in medical literature.
- **Option D:** This option is also incorrect as it does not represent a commonly acknowledged cause of fatty liver changes.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **fatty liver disease** can be caused by a variety of factors including **obesity, diabetes mellitus, and certain drugs**. Clinicians should be aware of the drugs that can induce fatty liver changes, such as **tetracyclines**, and manage patients accordingly to prevent progression to more severe liver damage.
## **Correct Answer:** .